González-Martín, A; Rubio, MJ; Heitz, F; Christensen, RD; Colombo, N; Van Gorp, T; Romeo, M; Ray-Coquard, I; Gaba, L; Leary, A; De Sande, LM; Lebreton, C; Redondo, A; Fabbro, M; Ginesta, MPB; Follana, P; Pérez-Fidalgo, JA; Rodrigues, M; Santaballa, A; Sabatier, R; Bermejo-Pérez, MJ; Lotz, JP; Pardo, B; Marquina, G; Sánchez-Lorenzo, L; Quindós, M; Estévez-García, P; Alía, EG; Manso, L; Casado, V; Kommoss, S; Tognon, G; Henry, S; Bruchim, I; Oaknin, A; Selle, F – 2024 – 10.1200/JCO.24.00668
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial – JOURNAL OF CLINICAL ONCOLOGY
by prodriguez | Jan 1, 2024 | Publicaciones - B-01 | 0 comments